Handa Pharmaceuticals Statistics
Total Valuation
TPEX:6620 has a market cap or net worth of TWD 12.09 billion. The enterprise value is 9.60 billion.
Market Cap | 12.09B |
Enterprise Value | 9.60B |
Important Dates
The last earnings date was Wednesday, April 2, 2025.
Earnings Date | Apr 2, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPEX:6620 has 158.25 million shares outstanding. The number of shares has increased by 7.81% in one year.
Current Share Class | n/a |
Shares Outstanding | 158.25M |
Shares Change (YoY) | +7.81% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 3.45% |
Owned by Institutions (%) | 1.28% |
Float | 102.50M |
Valuation Ratios
The trailing PE ratio is 23.56 and the forward PE ratio is 4.78.
PE Ratio | 23.56 |
Forward PE | 4.78 |
PS Ratio | 12.43 |
PB Ratio | 4.17 |
P/TBV Ratio | 4.22 |
P/FCF Ratio | 16.23 |
P/OCF Ratio | 16.20 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.75, with an EV/FCF ratio of 12.89.
EV / Earnings | 21.22 |
EV / Sales | 9.87 |
EV / EBITDA | 17.75 |
EV / EBIT | 18.08 |
EV / FCF | 12.89 |
Financial Position
The company has a current ratio of 17.75, with a Debt / Equity ratio of 0.01.
Current Ratio | 17.75 |
Quick Ratio | 17.71 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.07 |
Debt / FCF | 0.05 |
Interest Coverage | 2,294.41 |
Financial Efficiency
Return on equity (ROE) is 21.92% and return on invested capital (ROIC) is 15.71%.
Return on Equity (ROE) | 21.92% |
Return on Assets (ROA) | 14.66% |
Return on Invested Capital (ROIC) | 15.71% |
Return on Capital Employed (ROCE) | 17.57% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.43 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.76% in the last 52 weeks. The beta is 0.98, so TPEX:6620's price volatility has been similar to the market average.
Beta (5Y) | 0.98 |
52-Week Price Change | -39.76% |
50-Day Moving Average | 81.71 |
200-Day Moving Average | 76.50 |
Relative Strength Index (RSI) | 48.94 |
Average Volume (20 Days) | 612,362 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6620 had revenue of TWD 972.97 million and earned 452.32 million in profits. Earnings per share was 3.24.
Revenue | 972.97M |
Gross Profit | 971.68M |
Operating Income | 525.42M |
Pretax Income | 587.13M |
Net Income | 452.32M |
EBITDA | 529.31M |
EBIT | 525.42M |
Earnings Per Share (EPS) | 3.24 |
Balance Sheet
The company has 2.53 billion in cash and 36.89 million in debt, giving a net cash position of 2.49 billion or 15.74 per share.
Cash & Cash Equivalents | 2.53B |
Total Debt | 36.89M |
Net Cash | 2.49B |
Net Cash Per Share | 15.74 |
Equity (Book Value) | 2.90B |
Book Value Per Share | 20.56 |
Working Capital | 2.61B |
Cash Flow
In the last 12 months, operating cash flow was 746.52 million and capital expenditures -1.68 million, giving a free cash flow of 744.84 million.
Operating Cash Flow | 746.52M |
Capital Expenditures | -1.68M |
Free Cash Flow | 744.84M |
FCF Per Share | 4.71 |
Margins
Gross margin is 99.87%, with operating and profit margins of 54.00% and 46.49%.
Gross Margin | 99.87% |
Operating Margin | 54.00% |
Pretax Margin | 60.34% |
Profit Margin | 46.49% |
EBITDA Margin | 54.40% |
EBIT Margin | 54.00% |
FCF Margin | 76.55% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 1.35%.
Dividend Per Share | 1.00 |
Dividend Yield | 1.35% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 31.19% |
Buyback Yield | -7.81% |
Shareholder Yield | -6.46% |
Earnings Yield | 3.74% |
FCF Yield | 6.16% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TPEX:6620 has an Altman Z-Score of 54.71.
Altman Z-Score | 54.71 |
Piotroski F-Score | n/a |